Marc N. Gourevitch

Antiretroviral Therapy Adherence and Viral Suppression in HIV‐Infected Drug Users: Comparison of Self‐Report and Electronic Monitoring

Julia H. Arnsten, Penelope Demas, Homayoon Farzadegan et al. · Clinical Infectious Diseases · 2001 · 648 citations · Full text

Public Health, Pharmacotherapy, Electronic Health Records +15

Impact of Active Drug Use on Antiretroviral Therapy Adherence and Viral Suppression in HIV-infected Drug Users

Julia H. Arnsten, Penelope Demas, Richard W. Grant et al. · Journal of General Internal Medicine · 2002 · 478 citations · Full text

Public Health, Clinical Pharmacy, Pharmacotherapy +17

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

Julia H. Arnsten, Penelope Demas, Richard W. Grant et al. · Journal of General Internal Medicine · 2002 · 385 citations · Full text

Public Health, Clinical Pharmacy, Pharmacotherapy +17

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders

Joshua D. Lee, Peter D. Friedmann, Timothy W. Kinlock et al. · New England Journal of Medicine · 2016 · 317 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite Study

Frederick L. Altice, R. Douglas Bruce, Gregory M. Lucas et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 259 citations

Pharmacy, Pharmacotherapy, Outcomes Research +16